The Latest

Health insurance payers are currently facing significant upward pressure from rising medical costs, with trends projected at 8% to 9% through the end of 2026. A critical metric in this environment is the Medical Loss Ratio (MLR)—the specific percentage of premium income dedicated to medical claims. To manage this ratio effectively, payers must distinguish between clinical interventions that demonstrate genuine efficacy in diverse populations and those that only show results in highly controlled environments. The Limitation of Idealized Clinical Trials A primary challenge for payers is the "efficacy gap"—the discrepancy between how a drug or procedure performs in an idealized clinical trial versus how it performs in the general patient population. Traditional data sources often lack the granularity to identify why certain high-cost therapies fail to meet clinical markers in real-world settings. A primary feature of Circle Datasets is the provision of deterministic longitudinal data, which allows payers to transition from reactive claims processing to proactive risk management. By tracking a patient’s journey through a standardized protocol, Circle Datasets provide the verifiable evidence needed to negotiate outcome-based agreements with manufacturers. For example, in the management of high-cost specialty drugs, payers can use the deterministic evidence within a Circle Dataset to trigger rebates if a drug fails to meet specific clinical markers, such as HbA1C levels. Furthermore, the integration of structured Circle Datasets into AI-driven analysis can reduce fraud and waste by up to 50% by ensuring that all risk-adjustment documentation is fully supported by protocol-driven clinical evidence. This structural shift allows payers to stabilize their MLR by eliminating spending on ineffective therapies and ensuring high-precision risk adjustment.

For healthcare providers, the process of clinical data collection has historically functioned as a significant administrative burden with no direct financial return. Under legacy models, clinicians often enter data into electronic health records (EHR) only for that information to be siphoned by third-party brokers who monetize it without compensating the source . Furthermore, failure to meet evolving quality reporting standards can lead to severe financial consequences, including negative payment adjustments from the Centers for Medicare & Medicaid Services (CMS). The Burden of Quality Compliance Modern reimbursement is increasingly tied to value-based metrics. Providers who fail to satisfy CMS quality requirements—such as those under the Merit-based Incentive Payment System (MIPS) or Hospital Value-Based Purchasing—face negative payment adjustments of up to 9%. Conversely, those who demonstrate high-quality outcomes through standardized data are eligible for positive bonuses. However, the manual effort required to aggregate and verify this data often offsets the potential financial gains. The Circle Dataset Intervention: Direct License Revenue A primary feature of Circle Datasets is the transformation of data collection from an administrative cost into a diversified revenue stream . By utilizing the Split-IP model, participating physicians maintain majority ownership of the data they generate. When these datasets are licensed for regulatory, scientific, or commercial use, the platform contractually assigns the majority share of the licensing fees back to the contributing providers. This creates a profit center independent of fee-for-service reimbursement. Additionally, because the platform utilizes a standardized Observational Protocol, it automatically generates the deterministic evidence required to satisfy CMS quality incentives, enabling providers to secure positive payment adjustments while reducing the internal labor costs associated with registry participation

The traditional healthcare data economy is built upon an extraction model where third-party brokers monetize provider and patient information through "silent" de-identification clauses. This model frequently compromises patient privacy and provides no financial return to the original data sources. Furthermore, treating healthcare information as a neutral commodity rather than a rights-laden asset erodes trust between stakeholders and contributes to the misalignment of financial incentives that characterizes the modern evidence gap. The Data Brokerage Conflict Under the legacy framework, data is often siphoned away from the point of care without the explicit benefit or control of the clinicians and patients who generated it. This extraction process creates several systemic challenges

Precision Requires Design Healthcare data is not inherently precise — it must be made so. Every note, code, and measurement reflects the context and intention of its author. That variability, while humanly reasonable, is computationally disastrous. AI can only learn patterns as consistent as the data it receives. When inputs vary across sites or time, models drift. When definitions shift, results diverge. Precision, in this sense, is not an outcome — it’s a design choice. The Role of Observational Protocols Circle addresses variability at its source through Observational Protocols (OPs) — structured templates that define exactly what, when, and how data is captured. Each OP encodes: Clinical intent — the question being studied (e.g., post-surgical outcomes, metabolic response). Variables and metrics — standardized definitions aligned with controlled vocabularies like SNOMED, LOINC, and ICD. Follow-up intervals — ensuring longitudinal completeness. Consent and provenance rules — ensuring data is regulatory-ready from inception. By transforming care documentation into standardized observational events, OPs convert clinical routine into evidence-grade data capture. Turning Process into Structure Most health systems treat documentation as a byproduct. In the Circle model, it’s the primary instrument of discovery. When clinicians enter data through an OP-driven workflow, each field corresponds to a predefined variable linked to outcome tracking. This structure preserves context, eliminates redundancy, and guarantees interoperability. The difference is profound: Traditional systems store data after it’s created. Circle defines structure before it exists. That reversal is what makes its data inherently trustworthy. The Feedback Loop of Standardization Once an OP is implemented across multiple sites, the data it generates can be compared, aggregated, and analyzed without manual harmonization. The protocol itself becomes a federated learning framework — every institution contributes to a shared evidence base while maintaining local control. Each cycle of observation improves the precision of subsequent ones. Over time, the network becomes a living feedback system — self-calibrating, self-verifying, and self-improving. This is how observational medicine evolves into computational precision. Efficiency and Compliance by Default Structured data capture also means built-in regulatory alignment. Each OP automatically records consent, timestamps, and provenance metadata, making datasets inherently compliant with FDA RWE, EMA GMLP, and HIPAA standards. The result: Clinicians document once; data is instantly research- and audit-ready. Researchers spend less time cleaning data and more time interpreting it. Executives gain continuous visibility into performance metrics with traceable lineage. Precision becomes not an aspiration, but an operational property. Strategic Outcome Observational Protocols represent the convergence of clinical method and computational design. They replace fragmented data entry with a unified architecture of precision — turning healthcare documentation into an instrument of reproducibility. By embedding structure into process, Circle turns the variability of care into a measurable, auditable, and ultimately trustworthy data asset. In the era of AI-driven healthcare, protocol is precision — and precision is proof.

A core differentiator in modern healthcare information technology is the choice between deterministic evidence and inferred (probabilistic) data. This distinction determines the reliability, auditability, and ultimate regulatory value of the evidence generated. Inferred data utilizes statistical algorithms to estimate clinical events or patient journeys, often producing "confidence scores" rather than certainties. While useful for marketing or broad identity resolution, this probabilistic approach introduces a level of uncertainty that frequently leads to AI hallucinations and rejection by regulatory agencies. The Precision Gap In contrast, deterministic models rely on exact, verified identifiers—such as Unique Device Identifiers (UDI) for surgical implants or exact patient credentials—to provide precise outcomes. These models operate on rule-based "yes/no" logic, which is essential for regulated environments where transparency is mandatory.